my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Takeda Pharmaceutical Company Limited announced strategic measures to better align its global workforce and consolidate site operations in order to integrate legacy Nycomed operations, strengthen its presence in more than 70 countries, adapt to changing market conditions and maintain a focus on grow more
Takeda Pharmaceutical Company Limited announced that the European Commission has granted marketing authorisation for Edarbi® (azilsartan medoxomil), a new once-daily angiotensin receptor blocker (ARB) (also known as angiotensin II receptor antagonist [AIIRA]) for the treatment of essential hypertens more
H. Lundbeck A/S and Takeda Pharmaceutical Company Limited announced the initiation of a phase III clinical trial in Japan for Lu AA21004 in patients with major depressive disorder (MDD).This randomized, double-blind and multi-center phase III clinical trial is expected to enroll approximately 360 pa more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Osteopenia Therapeutics market. The report identifies the more
TechNavio’s analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs ma more
glossary media library contact us close Pipeline Click on bar or (i) in the in pipeline for more information Our Proprietary Programs Co-Developed Programs ABOUT OUR PARTNERS Partnered Programs Joint Ventures Development Pipeline Programs Discovery Development Phase I Phase II Phase more
| | Home | Sitemap | Contact Us Search Ranbaxy for Quick Links Select Link About us Board of Directors Executive Team Corporate Social Responsibility Business Development Annual Report 2007 Corporate Presentation Media Contacts Select a Country Australia Austria Baltics Belg more
Skip to content Management Team Board of Directors Scientific Advisors Clinical Advisors Contact Us Directions FLT3 Kinase AURORA Kinase BRAF Kinase Press Releases Events Management Team Board of Directors Scientific Advisors Clinical Advisors Contact Us Directions Corporate Officers Alan Lewis Ch more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
